Domain Therapeutics - Articles and news items

Domain Therapeutics logo

Domain Therapeutics appoints Professor Michel Bouvier as chairman of the Scientific Advisory Board

Industry news / 22 September 2014 / Domain Therapeutics

The world-renowned GPCR specialist will assemble a team of experts in drug discovery and development to guide Domain’s programs…

Domain Therapeutics and Merck Serono announce an agreement to develop drugs for Parkinson’s disease

Industry news, News / 17 January 2011 / Andrew Lloyd & Associates

Agreement covers metabotropic glutamate receptor 4 (mGluR4) Positive Allosteric Modulator (PAM) drugs targeting Parkinson’s disease…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...